SCHEMBL6754199

SCHEMBL6754199

CN(C)CCCn1cc2c[c]ccc2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
TERT O14746 1/20 0.32
BRAF P15056 1/20 0.32
MAPK3 P27361 1/20 0.32
MAPK1 P28482 1/20 0.32
NR1I2 O75469 1/20 0.31
POLB P06746 1/20 0.31
AHR P35869 1/20 0.31
RAD52 P43351 1/20 0.31
RCE1 Q9Y256 1/20 0.31
ALDH1A1 P00352 3/20 0.31
CYP2D6 P10635 3/20 0.31
LMNA P02545 3/20 0.31
MAPT P10636 3/20 0.31
SLC22A1 O15245 2/20 0.31
PRNP P04156 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752490 0.91 CNR2 (0.34) HTR2AHTR2CKCNH2
SCHEMBL3482976 0.80 ADORA3 (0.32) ADORA3
SCHEMBL28267672 0.79 KMT2A (0.41) KDM4EKMT2AMEN1GLAGAA
SCHEMBL3482975 0.77 MEN1 (0.34) KMT2AMEN1
SCHEMBL188339 0.77 NOTUM (0.33) SMN1; SMN2
SCHEMBL15516643 0.76 ALDH1A1 (0.38) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL694373 0.72 ADORA2A (0.42) POLBLMNAMAPTADORA3
SCHEMBL19461954 0.71 KDM4E (0.54) KDM4EKMT2AMEN1GLAGAA
SCHEMBL29968984 0.71 EGFR (0.37) KDM4EBRAFMAPK3MAPK1RAD52
SCHEMBL1100026 0.71 KDM4E (0.43) KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US claimed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US claimed
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US disclosed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077646-A1 Indole nitriles TPH1, IDO1, NAT1 KDM4E 3071/4885KMT2A 3067/4885MEN1 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.